In Other News

• Whole-Blood RNA Test Predicts Disease Trajectory and Treatment Response

• Blood-Based Epigenetic Test Predicts GLP-1 Response and Tracks Treatment Effects

• Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response

• Study Links Abnormal Gene Splicing to Treatment Response in Metastatic Kidney Cancer

• Patient-Derived Tumor-on-a-Chip Recapitulates Pancreatic Microenvironment for Drug Testing

• Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype

• AI System Analyzes Routine Pathology Slides to Predict Cancer Outcomes

• FDA Clears Blood-Based Companion Diagnostic for Advanced Breast Cancer Therapy

• Tumor Genomic Testing Guides Immunotherapy Selection in Pituitary Tumors

• Rapid Tongue Swab Molecular Test Detects Pulmonary Tuberculosis at Point of Care

• New Platform Captures Extracellular Vesicles for Early Cancer Detection

• Research Reveals How Some Aplastic Anemia Patients Recover Bone Marrow Function

• Liquid Biopsy Predicts Immunotherapy Response in Breast Cancer

• Rapid Tongue Swab Molecular Test Detects Pulmonary Tuberculosis at Point of Care

• Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk

• New Blood Test Distinguishes Pancreatic Cancer From Benign Disease

• Noninvasive Test Confirms High-Risk Prenatal Screening Results from Blood

• Point-of-Care Tests Could Expand Access to Mpox Diagnosis

• T-Cell Senescence Profiling May Predict CAR T Responses

• Machine-Learning Genetic Risk Score Improves Early Prediction of Type 1 Diabetes

• Genomic Classifiers Improve Risk Stratification and Treatment Selection in Urologic Cancers

• T-Cell Senescence Profiling May Predict CAR T Responses

• Single-Cell Sequencing Assay Identifies Protective Clones Linked to Remission in Aplastic Anemia